GlassScriptPhysician profile
Ryan C Owen
NPI 1679836977
$12,997.85
in general payments reported to CMS, 2019-2025
39 companies · $3,119 in 2025
The $3,119 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,822 · 2020: $430 · 2021: $1,162 · 2022: $2,048 · 2023: $2,300 · 2024: $2,116 · 2025: $3,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,788 · Travel and Lodging: $1,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,788.18 |
| Travel and Lodging | $1,747.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,463.08 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Ams 800 Artificial Urinary Sphincter |
| Medtronic, INC. | $1,986.86 | 2022-2025 | Interstim, Altaviva |
| Intuitive Surgical, INC. | $1,419.38 | 2023-2024 | Da Vinci Surgical System |
| Astellas Pharma US INC | $1,275.29 | 2019-2025 | Myrbetriq, Xtandi |
| Neotract INC. | $1,065.64 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $853.72 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $648.78 | 2019-2025 | Titan, Saffron |
| Janssen Biotech, INC. | $400.28 | 2019-2025 | Erleada |
| Pfizer INC. | $286.26 | 2019-2025 | |
| Abbvie INC. | $200.12 | 2019-2025 | |
| Coopersurgical, INC. | $166.37 | 2023-2024 | Supercut Hysterectomy Scissors, Summit Doppler, Advincula Delineator Uterine Manipulator |
| Endo Pharmaceuticals INC. | $159.88 | 2019-2023 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $147.77 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Axonics, INC. | $93.65 | 2021-2024 | Axonics |
| Dendreon Pharmaceuticals LLC | $74.80 | 2024-2025 | Provenge |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.